THE CLINICAL NEED
Heart failure is a complex, evolving condition. Understanding changes in cardiovascular pressures, fluid status, and cardiac mechanics can help inform more personalized approaches to monitoring and care.
People living with heart failure worldwide (2017 estimate).
Five-year mortality after diagnosis.
Estimated annual economic burden: Europe and United States, respectively.
References: [1] Eur J Prev Cardiol. 2021;28:1682–1690 · [2] Circulation. 2021;143:e254–e743 · [3] Eur Heart J. 2025;46:3069–3078 · [4] Circ Heart Fail. 2013;6:606–619.
THE CLINICAL CHALLENGE
Conventional monitoring often relies on symptoms, weight and blood pressure, discussed during phone calls or clinic visits. These approaches have limitations: by the time noticeable symptoms appear, deterioration may already be advanced.
01
Patients can experience progressive deterioration and recurrent decompensation despite ongoing treatment. Noticeable symptoms may emerge only after the condition has already worsened.
02
Symptoms, weight and blood pressure provide useful information, but may not capture all of the interacting changes in heart failure. A single physiological parameter provides only part of the picture.
03
Routine data review, patient follow-up and medication management place demands on clinical teams. Monitoring models need to account for this operational workload.
MULTIPARAMETRIC MONITORING
Cardiovascular pressures, thoracic fluid status and cardiac mechanics reflect different aspects of a complex condition. Complementary physiological measurements can provide a broader picture than any one measurement alone.
FORESEE is developing an intravascular sensing platform designed to combine four physiological parameters:
Hemodynamic information reflecting changes in pulmonary artery pressure.
Electrical measurements sensitive to changes in thoracic fluid status.
Information related to the heart's mechanical activity.
An additional physiological measurement that complements the monitoring platform.
SCALABLE HEART FAILURE CARE
Hospitals need care models capable of supporting large heart failure populations without creating an unsustainable burden of routine data review. Collecting more information is only one part of the challenge; that information also needs to fit into a structured clinical workflow.
Structured monitoring, patient empowerment and clinician oversight may help shape care models that can serve larger populations. FORESEE is exploring this approach through its intended physician-directed patient self-management model.
(Technology under development. Improved workload efficiency and clinical outcomes have not been demonstrated for this intended service.)
PHYSICIAN-DIRECTED PATIENT SELF-MANAGEMENT
FORESEE's intended model is for patients to participate in routine home monitoring and structured self-management within a physician-defined care plan.
Patients would take routine measurements at home and follow the activities and instructions defined in their individual care plan.
Clinical teams retain oversight and responsibility for treatment decisions and escalation pathways. Treatment changes remain physician-directed.
(Technology under development, not an already validated clinical service.)
HOW FORESEE WORKS
The platform under development brings together an implant, an external unit, a delivery system and a digital application. Its intended workflow has four stages:
01
A wireless multiparametric intravascular microsensor is being developed to obtain physiological information. The platform includes a delivery system designed to deploy the microsensor in a branch of the pulmonary artery.
02
An external unit is designed to wirelessly power the microsensor and acquire data through communication with it. FORESEE's powering and communication approach is intended to avoid bulky components within the implant.
03
The intended routine is an approximately five-minute measurement at home. This is a target workflow under development, rather than a validated clinical service.
04
An application would show patient parameters, trigger alerts and support monitoring and care. Information would be reviewed within a physician-defined plan, with clinical teams responsible for decisions and escalation.
SCIENTIFIC FOUNDATION
FORESEE is a spin-off of Universitat Pompeu Fabra (UPF) - Barcelona. Its work builds on research in bioelectrical phenomena and wireless powering of implantable devices.